Episode 123: Opening Access to Ibogaine - A Conversation with Bryan Hubbard, CEO of Americans for Ibogaine episode artwork

EPISODE · Sep 17, 2025 · 1H 7M

Episode 123: Opening Access to Ibogaine - A Conversation with Bryan Hubbard, CEO of Americans for Ibogaine

from Recovery Lab · host Normalizing Recovery

In this episode, hosts David Sugg, Brynn Knox, and Daniel Anderson sit down with Bryan Hubbard, the inaugural CEO of Americans for Ibogaine, to explore his mission to expand education, access, and responsible pathways for ibogaine as a potential therapeutic option for brain injuries, substance use disorders, and co-occurring mental health conditions. Bryan brings decades of leadership at the intersection of law, public policy, and community impact. He shares insights from: Leading the Kentucky Opioid Abatement Advisory Commission and advancing reforms across disability policy, child support enforcement, Medicaid systems, and judicial responses to mental health and substance use Building diverse coalitions and crafting policy solutions aimed at saving lives and improving systems His tenure with the American Ibogaine Initiative and the REID Foundation Earlier public service roles in the Kentucky Attorney General’s Office, the Department of Income Support, and statewide commissions on mental health, mine safety, child support guidelines, and recovery-ready communities A personal arc that began in Virginia’s coalfields and a legal career that witnessed the early stages of the opioid crisis We discuss what responsible ibogaine frameworks could look like in the United States, the role of public education and evidence generation, ethical considerations, and how advocates, clinicians, policymakers, and families can work together to widen safe, equitable access for people in need. Bryan also reflects on the research gaps, risk management, and the practical steps AFI is taking to move the conversation—and the science—forward.   Note: This conversation is for informational purposes only and is not medical advice. Ibogaine is not approved for medical use in many jurisdictions; risks and benefits should be evaluated with qualified professionals.   #RecoveryLabPodcast #Ibogaine #AmericansForIbogaine #AddictionRecovery #MentalHealth #BrainInjury #OpioidCrisis #HarmReduction #PolicyChange #PublicHealth #RecoveryCommunity #EvidenceBasedCare #HealthEquity #BryanHubbard #Episode123 This episode is produced by Daniel Anderson at Audio Alchemy Productions.

In this episode, hosts David Sugg, Brynn Knox, and Daniel Anderson sit down with Bryan Hubbard, the inaugural CEO of Americans for Ibogaine, to explore his mission to expand education, access, and responsible pathways for ibogaine as a potential therapeutic option for brain injuries, substance use disorders, and co-occurring mental health conditions. Bryan brings decades of leadership at the intersection of law, public policy, and community impact. He shares insights from: Leading the Kentucky Opioid Abatement Advisory Commission and advancing reforms across disability policy, child support enforcement, Medicaid systems, and judicial responses to mental health and substance use Building diverse coalitions and crafting policy solutions aimed at saving lives and improving systems His tenure with the American Ibogaine Initiative and the REID Foundation Earlier public service roles in the Kentucky Attorney General’s Office, the Department of Income Support, and statewide commissions on mental health, mine safety, child support guidelines, and recovery-ready communities A personal arc that began in Virginia’s coalfields and a legal career that witnessed the early stages of the opioid crisis We discuss what responsible ibogaine frameworks could look like in the United States, the role of public education and evidence generation, ethical considerations, and how advocates, clinicians, policymakers, and families can work together to widen safe, equitable access for people in need. Bryan also reflects on the research gaps, risk management, and the practical steps AFI is taking to move the conversation—and the science—forward.   Note: This conversation is for informational purposes only and is not medical advice. Ibogaine is not approved for medical use in many jurisdictions; risks and benefits should be evaluated with qualified professionals.   #RecoveryLabPodcast #Ibogaine #AmericansForIbogaine #AddictionRecovery #MentalHealth #BrainInjury #OpioidCrisis #HarmReduction #PolicyChange #PublicHealth #RecoveryCommunity #EvidenceBasedCare #HealthEquity #BryanHubbard #Episode123 This episode is produced by Daniel Anderson at Audio Alchemy Productions.

NOW PLAYING

Episode 123: Opening Access to Ibogaine - A Conversation with Bryan Hubbard, CEO of Americans for Ibogaine

0:00 1:07:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Recovery Lab?

This episode is 1 hour and 7 minutes long.

When was this Recovery Lab episode published?

This episode was published on September 17, 2025.

What is this episode about?

In this episode, hosts David Sugg, Brynn Knox, and Daniel Anderson sit down with Bryan Hubbard, the inaugural CEO of Americans for Ibogaine, to explore his mission to expand education, access, and responsible pathways for ibogaine as a potential...

Can I download this Recovery Lab episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!